Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups
- PMID: 22982095
- DOI: 10.1016/j.cgh.2012.09.007
Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups
Abstract
Background & aims: The incidence of hepatocellular carcinoma (HCC) and associated risk factors in patients with alcoholic cirrhosis are not well defined. Surveillance for HCC among patients with cirrhosis who do not have hepatitis B is cost effective only if the expected risk of HCC exceeds 1.5% per year. We performed a prospective study to determine the incidence of HCC among patients with alcoholic cirrhosis and to identify risk factors.
Methods: We analyzed data from a surveillance program of 450 patients, aged 40 to 75 years, with alcoholic cirrhosis of Child-Pugh class A or B; patients were enrolled at the liver unit of a tertiary center from September 1992 through March 2010. Data were collected on 20 demographic, clinical, and laboratory variables at the start of the study. Patients were examined every 3 to 6 months for 5 years to identify risk factors for HCC; incidence was determined from a median follow-up time of 42 months.
Results: Over the follow-up period, 62 patients developed HCC (43 in the first 5 y of follow-up evaluation), with an annual incidence of 2.6%. By using multivariate analysis, age 55 years and older (hazard ratio, 2.39; 95% confidence interval, 1.27-4.51) and platelet counts less than 125 × 10(3)/mm(3) (hazard ratio, 3.29; 95% confidence interval, 1.39-7.85) were associated independently with the development of HCC. These variables were used to define 3 risk groups. The annual incidence of HCC in the group without either of these factors was 0.3% (n = 93), the annual incidence with 1 factor was 2.6% (n = 228), and the annual incidence with both factors was 4.8% (n = 129) (P < .0001).
Conclusions: The annual incidence of HCC among patients with alcoholic cirrhosis of Child-Pugh class A or B is around 2.5%. Age and platelet count can be used to classify the patients in 3 different risk groups for HCC development within the next 5 years.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.Clin Gastroenterol Hepatol. 2006 Aug;4(8):1062-8. doi: 10.1016/j.cgh.2006.05.013. Epub 2006 Jul 14. Clin Gastroenterol Hepatol. 2006. PMID: 16844421
-
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690
-
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.Hepatology. 2003 Mar;37(3):520-7. doi: 10.1053/jhep.2003.50093. Hepatology. 2003. PMID: 12601348
-
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2023 May;21(5):1169-1177. doi: 10.1016/j.cgh.2022.06.032. Epub 2022 Aug 5. Clin Gastroenterol Hepatol. 2023. PMID: 35940513 Free PMC article. Review.
-
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2017 Aug;15(8):1207-1217.e4. doi: 10.1016/j.cgh.2017.02.006. Epub 2017 Feb 12. Clin Gastroenterol Hepatol. 2017. PMID: 28215616 Free PMC article. Review.
Cited by
-
A scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis.Sci Rep. 2022 Feb 2;12(1):1717. doi: 10.1038/s41598-022-05196-w. Sci Rep. 2022. PMID: 35110551 Free PMC article.
-
A global view of hepatocellular carcinoma: trends, risk, prevention and management.Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31439937 Free PMC article. Review.
-
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.Cancer Metastasis Rev. 2023 Sep;42(3):629-652. doi: 10.1007/s10555-023-10084-4. Epub 2023 Feb 2. Cancer Metastasis Rev. 2023. PMID: 36729264 Review.
-
Alcoholic liver disease: A current molecular and clinical perspective.Liver Res. 2018 Dec;2(4):161-172. doi: 10.1016/j.livres.2018.11.002. Epub 2018 Dec 12. Liver Res. 2018. PMID: 31214376 Free PMC article.
-
Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma.Drugs Aging. 2021 Jul;38(7):579-591. doi: 10.1007/s40266-021-00871-5. Epub 2021 Jun 21. Drugs Aging. 2021. PMID: 34152589 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical